Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II open-label non-randomized study of cetuximab plus chemotherapy in inoperable EGFR-expressing gallbladder and biliary tract carcinoma
2006-004981-14Phase 2Completed
- Sponsor
- Országos Onkológiai Intézet
- Start
- Oct 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cetuximab in biliary cancer and gallbladder cancer, sponsored by Országos Onkológiai Intézet. Primary endpoint: Response rate. Started Oct 2006; status: completed.
02
Drugs
cetuximab
03
Conditions
biliary cancergallbladder cancer
Beyond the preview
Go deeper on 2006-004981-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004981-14.